The overall aim of this study is to develop and test a tailored Internet-delivered psychological treatment for patients with mild to moderate major depression and comorbid anxiety symptoms and compare its efficacy to a non-tailored treatment and to an active control group.
Internet-delivered cognitive behaviour therapy (CBT) has emerged as a promising way to administer evidence-based psychological treatments. Mild to moderate major depression has previously been found to treatable via the Internet, with the provision that minimal therapist guidance is given. However, previous research has not taken the issue of comorbidity into account. It is well known that major depression often is accompanied by anxiety and in addition the symptom profile in major depression may differ substantially. The idea behind the proposed research is to tailor the Internet intervention according to the symptom profile. By used a large set of treatment modules (text-based) we aim to diagnose and then prescribe modules. In a randomized trial we want to compare this procedure (e.g., tailored CBT) with the standard Internet-delivered CBT. We will also include a control group in the form of a supervised online discussion group who will later receive CBT.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
121
This intervention contains 8-10 text-based self-help modules in which 4 modules are fixed (the first three and the last) and the rest are "prescribed following the diagnostic telephone interview. These modules contain material on panic disorder, social phobia, stress management, assertiveness training, concentration, relaxation among other things.
Specific text-based self-help for depression, which has previously been tested in three previous randomized trials. Anxiety symptoms will not be covered, but insomnia is included as a module together with advice on health.
Participants take part of an online discussion group which are monitored daily. New discussion topics on depression are introduced every week.
Linköping University, Department of Behavioral Sciences and Learning
Linköping, Sweden
Beck Depression Inventory (BDI)
Time frame: One week before the treatment starts
Beck Depression Inventory (BDI)
Time frame: Five weeks after treatment started
Beck Depression Inventory (BDI)
Time frame: At treatment termination (10 weeks)
Beck Depression Inventory (BDI)
Time frame: 6 month after treatment ended
Beck Depression Inventory (BDI)
Time frame: 2 years after treatment ended
Beck Anxiety Inventory (BAI)
Time frame: One week before the treatment starts
Montgomery Åsberg Depression Rating Scale Self-report (MADRS-S)
Time frame: One week before the treatment starts
Quality of Life Inventory (QOLI)
Time frame: One week before the treatment starts
Beck Anxiety Inventory (BAI)
Time frame: Five weeks after treatment started
Beck Anxiety Inventory (BAI)
Time frame: At treatment termination (10 weeks)
Beck Anxiety Inventory (BAI)
Time frame: 6 month after treatment ended
Beck Anxiety Inventory (BAI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: 2 years after treatment ended
Montgomery Åsberg Depression Rating Scale Self-report (MADRS-S)
Time frame: Five weeks after treatment started
Montgomery Åsberg Depression Rating Scale Self-report (MADRS-S)
Time frame: At treatment termination (10 weeks)
Montgomery Åsberg Depression Rating Scale Self-report (MADRS-S)
Time frame: 6 month after treatment ended
Montgomery Åsberg Depression Rating Scale Self-report (MADRS-S)
Time frame: 2 years after treatment ended
Quality of Life Inventory (QOLI)
Time frame: Five weeks after treatment started
Quality of Life Inventory (QOLI)
Time frame: At treatment termination (10 weeks)
Quality of Life Inventory (QOLI)
Time frame: 6 month after treatment ended
Quality of Life Inventory (QOLI)
Time frame: 2 years after treatment ended